share_log

博瑞医药(688166.SH):拟将博泽格霖49%股权转让给博诺康源

Gelonghui Finance ·  May 31, 2022 07:55

格隆汇5月31日丨博瑞医药(688166.SH)公布,公司拟对持有的博泽格霖(山东)药业有限公司(简称“博泽格霖”)股份及持有方式进行调整,计划将持有的博泽格霖49%的股权(简称“标的股权”)转让给博诺康源(北京)药业科技有限公司(简称“博诺康源”),转让价款为980万元。

此次交易完成后,博瑞医药将继续持有博泽格霖的控股股东博诺康源14.2857%股权,但不再持有博泽格霖的股权。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment